Luisa M.P.F Amaral

Dr. Luisa M.P.F Amaral

REQUIMTE/LAQV/Molecular Synthesis, Porto, Portugal
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 1995 in The Journal of Chemical Thermodynamics
Verified
Journal Article
Closed access
MSManuel A.V. Ribeiro da Silva
Manuel A.V. Ribeiro da Silva
MRM.Agostinha R.Matos
M.Agostinha R.Matos
LALuisa M.P.F Amaral
Luisa M.P.F Amaral

1 November 1999 in The Journal of Physical Chemistry A
Verified
Journal Article
Closed access
OMOtilia Mó
Otilia Mó
MYManuel Yáñez
Manuel Yáñez
MRMaría Victoria Roux
María Victoria Roux
PJPilar Jiménez
Pilar Jiménez
Juan Z. Dávalos-PradoJuan Z. Dávalos-Prado
Juan Z. Dávalos-Prado
JLJoel F. Liebman
Joel F. Liebman

Verified
Journal Article
Open access
PDF file
LALuisa M.P.F Amaral
Luisa M.P.F Amaral
Tânia MonizTânia Moniz
Tânia Moniz
Maria NevesMaria Neves
Maria Neves
Maria RangelMaria Rangel
Maria Rangel
Over the last four decades, vanadium compounds have been extensively studied as potential antidiabetic drugs. With the present review, we aim at presenting a general overview of the most promising compounds and the main results obtained with in vivo studies, reported from 1899–2023. The chemistry of vanadium is explored, discussing the importance of the structure and biochemistry of vanadate and the impact of its similarity with phosphate on the antidiabetic effect. The spectroscopic characterization of vanadium compounds is discussed, particularly magnetic resonance methodologies, emphasizing its relevance for understanding species activity, speciation, and interaction with biological membranes. Finally, the most relevant studies regarding the use of vanadium compounds to treat diabetes are summarized, considering both animal models and human clinical trials. An overview of the main hypotheses explaining the biological activity of these compounds is presented, particularly the most accepted pathway involving vanadium interaction with phosphatase and kinase enzymes involved in the insulin signaling cascade. From our point of view, the major discoveries regarding the pharmacological action of this family of compounds are not yet fully understood. Thus, we still believe that vanadium presents the potential to help in metabolic control and the clinical management of diabetes, either as an insulin-like drug or as an insulin adjuvant. We look forward to the next forty years of research in this field, aiming to discover a vanadium compound with the desired therapeutic properties.

1 August 2003 in The Journal of Chemical Thermodynamics
Verified
Journal Article
Closed access
MSManuel A.V. Ribeiro da Silva
Manuel A.V. Ribeiro da Silva
LLLuı́s M.Spencer S. Lima
Luı́s M.Spencer S. Lima
LALuisa M.P.F Amaral
Luisa M.P.F Amaral
AFAna I.M.C.L. Ferreira
Ana I.M.C.L. Ferreira
José R. B. GomesJosé R. B. Gomes
José R. B. Gomes

1 June 2006 in The Journal of Chemical Thermodynamics
Verified
Journal Article
Closed access
MSManuel A.V. Ribeiro da Silva
Manuel A.V. Ribeiro da Silva
LALuisa M.P.F Amaral
Luisa M.P.F Amaral
ASAna Filipa L.O.M. Santos
Ana Filipa L.O.M. Santos
José R. B. GomesJosé R. B. Gomes
José R. B. Gomes

1 February 2012 in The Journal of Chemical Thermodynamics
Verified
Journal Article
Closed access
Manuel J.S. MonteManuel J.S. Monte
Manuel J.S. Monte
SPSónia P. Pinto
Sónia P. Pinto
AFAna I.M.C. Lobo Ferreira
Ana I.M.C. Lobo Ferreira
LALuisa M.P.F Amaral
Luisa M.P.F Amaral
VFVera Freitas
Vera Freitas
Maria D.M.C. Ribeiro da SilvaMaria D.M.C. Ribeiro da Silva
Maria D.M.C. Ribeiro da Silva